Capecitabine Has Edge in CRT for Pancreatic Ca
SAN FRANCISCO (MedPage Today) -- When paired with chemoradiotherapy, capecitabine offered better survival and toxicity outcomes than gemcitabine in locally advanced pancreatic cancer, researchers reported here.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Primary Care | Toxicology | Xeloda